IL-1β is involved in the onset of acute local or systemic inflammation and contributes to a variety of chronic noninfectious diseases, including ischemic injury, atherosclerosis, type 2 diabetes, and osteoarthritis. This evidence concerns the gene IL1B and type 2 diabetes mellitus.